Mobile-health Network Solutions ROE 1970-1969 | MNDR

Current and historical return on equity (ROE) values for Mobile-health Network Solutions (MNDR) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Mobile-health Network Solutions ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.701B $0.000B
Mobile-health Network Solutions is a telehealth solutions provider principally in Singapore. The company offer users with a range of seamless and hassle-free telehealth solutions, which encompasses teleconsultation services, including the issuance of electronic medical certificates and delivery of medications to user homes, as well as other personalized services such as weight management programs. Mobile-health Network Solutions is based in Singapore.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $35.527B 19.51
Inspire Medical Systems (INSP) United States $7.610B 0.00
IRhythm Technologies (IRTC) United States $3.451B 0.00
Axonics (AXNX) United States $3.424B 0.00
10x Genomics (TXG) United States $3.133B 0.00
Azenta (AZTA) United States $2.932B 238.96
Olink Holding AB (publ) (OLK) Sweden $2.862B 0.00
Enovis (ENOV) United States $2.859B 21.19
Hims & Hers Health (HIMS) United States $2.622B 0.00
Privia Health (PRVA) United States $2.184B 96.89
Schrodinger (SDGR) United States $1.677B 0.00
Omnicell (OMCL) United States $1.345B 46.49
Phreesia (PHR) United States $1.255B 0.00
Definitive Healthcare (DH) United States $0.823B 0.00
Standard BioTools (LAB) United States $0.734B 0.00
Fulgent Genetics (FLGT) United States $0.635B 0.00
Talkspace (TALK) United States $0.531B 0.00
Health Catalyst (HCAT) United States $0.386B 0.00
Pulmonx (LUNG) United States $0.361B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.331B 0.00
Clover Health Investments (CLOV) United States $0.319B 0.00
Butterfly Network (BFLY) United States $0.192B 0.00
P3 Health Partners (PIII) United States $0.189B 0.00
Outset Medical (OM) United States $0.155B 0.00
American Well (AMWL) United States $0.151B 0.00
Augmedix (AUGX) United States $0.130B 0.00
MSP Recovery (LIFW) United States $0.129B 0.00
TruBridge (TBRG) United States $0.125B 5.32
111 (YI) China $0.094B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.068B 0.00
NantHealth (NHIQ) United States $0.058B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
Zepp Health (ZEPP) China $0.056B 0.00
Movano (MOVE) United States $0.050B 0.00
EUDA Health Holdings (EUDA) Singapore $0.046B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.033B 0.00
Akili (AKLI) United States $0.032B 0.00
Bullfrog AI Holdings (BFRG) United States $0.024B 0.00
Cue Health (HLTH) United States $0.022B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.014B 0.00
Biotricity (BTCY) United States $0.012B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Syra Health (SYRA) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00